Abstract Objective Epstein-Barr virus (EBV) is responsible for 90% of infectious mononucleosis (IM) cases. Clinically, IM often presents with fever, fatigue, sore throat, and lymphadenopathy, but can also result in prolonged symptoms requiring hospitalization. As little is known about the impact of IM on healthcare res...
M. Georgieva, Zheng Wang, Tian-Yi Lu et al.· Current Medical Research and...· 1 citation
Randomized controlled trials (RCTs) remain the cornerstone of causal inference on the safety and efficacy of medicinal products. But their limited follow-up, controlled settings, and narrowly defined data collection to balance the burden to patients and maintain study feasibility often results in unaddressed important...
A. Meinecke, J. Diaz-Decaro, Kathleen M. Gavin et al.· Frontiers in Pharmacology· 1 citation
Key Points Public health faces increasingly complex challenges for pharmacoepidemiology: monitoring and evaluating the safety and effectiveness of medicines in real‐world populations, predicting and responding to emerging diseases and outbreaks, overcoming inequities in drug access and outcomes, managing risks from wid...
G. Sarri, J. Diaz-Decaro, M. Burcu et al.· Pharmacoepidemiology and Dru...· 0 citations
We use cookies to run the site and, with your consent, for analytics and to show ads.
See our Cookie Policy.